CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Biopsyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03211325
NCT03211325N/ACompleted
CompareCT.gov

Identification of Transient Receptor Potential (TRP) Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.

University Hospital, Grenoble·interventional·Posted Jul 7, 2017·Updated Apr 9, 2020

In Brief

A clinical study evaluating Biopsy for Raynaud's Phenomenon Isolated Primary and 2 related conditions. Completed, enrolled 29 participants across 1 site.

Detailed Summary

The investigators seek to perform a comparative transcriptome analysis of TRP channels residing in the skin between primary and scleroderma secondary Raynaud's phenomenon and healthy subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRaynaud's Phenomenon Isolated Primary, Raynaud's Phenomenon (Secondary), Healthy
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 7, 2017
Enrollment StartOct 18, 2016
Primary CompletionMar 17, 2019
Study CompletionJun 27, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.0 years ago

Interventions

Biopsyprocedure